author

Main Image Credit: 
Dr. Harley Kornblum, UCLA

This article is reprinted with permission from its author, Kim Irwin, UCLA Broad Stem Cell Research Center.  The article features researcher Dr. Harley Kornblum, a speaker at Accelerate Brain Cancer Cure's Annual Scientific Meeting in 2009.

Researchers with UCLA’s Jonsson Comprehensive Cancer Center have developed and used a high-throughput molecular screening approach that identifies and characterizes chemical compounds that can target the stem cells that are responsible for creating deadly brain tumors.

A University of Alabama at Birmingham study has identified a gene deletion in nearly 25 percent of all glioblastoma cases that is believed to be responsible for poor patient outcomes. The discovery could lead to better diagnosis and targeted treatments with drugs that are currently available.

Deck: 
Duke Vaccine Extends Life for Brain Cancer Patients

October 4, 2021 - A new vaccine added to standard therapy appears to offer a survival advantage for patients suffering from glioblastoma (GBM), the most deadly form of brain cancer, according to a study from researchers at Duke University Medical Center and The University of Texas MD Anderson Cancer Center.

The vaccine also knocks out a troublesome growth factor that characterizes the most aggressive form of the disease.

Share |

Join us in our fight for a cure!

Twitter